(99 days)
Not Found
No
The description focuses on standard electrical stimulation technology with adjustable parameters controlled by a microprocessor and software, without mentioning any AI or ML capabilities for analysis, adaptation, or learning.
Yes
The device is described as a transcutaneous electrical nerve stimulator for pain relief and/or powered muscle stimulator used for therapeutic purposes such as relaxation of muscle spasms, preventing muscle atrophy, increasing blood circulation, muscle re-education, preventing venous thrombosis, and maintaining range of motion.
No
The device is described as a transcutaneous electrical nerve stimulator for pain relief and/or powered muscle stimulator, and its indications for use focus on therapeutic applications such as symptomatic pain relief, muscle relaxation, and prevention of disuse atrophy. There is no mention of diagnostic functions.
No
The device description explicitly states that the device consists of a stimulus generator and electrodes, which are hardware components. While software controls the operation modes, the core function relies on physical electrical stimulation delivered through hardware.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use/Indications for Use: The indications for use clearly describe the device's purpose as providing symptomatic relief of chronic intractable pain and/or powered muscle stimulation. These are therapeutic applications, not diagnostic ones.
- Device Description: The device description explains that it's a transcutaneous electrical nerve stimulator (TENS) and/or powered muscle stimulator that applies electrical current to electrodes on the patient's skin. This mechanism of action is for delivering electrical stimulation to the body, not for analyzing samples taken from the body.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening.
Therefore, the information provided strongly indicates that this device is a therapeutic medical device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
Indications For Use (Available for GM3X0T/GM3AX0T, GM3X0PP/GM3AX0PP, and TENS function of GM3X0TE/GM3AX0TE):
This device is a prescription device and only for symptomatic relief of chronic intractable pain.
Indications For Use (Available for GM3X0E/GM3AX0E, & 'EMS function' of GM3X0TE/GM3AX0TE):
- Relaxation of muscle spasms. .
- Prevention or retardation of disuse atrophy.
- Increasing local blood circulation.
- Muscle re-education. .
- Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis. ●
- Maintaining or increasing range of motion. .
Indications For Use (Available for GM3X0PE/GM3AX0PE):
- Relaxation of muscle spasms. .
Product codes (comma separated list FDA assigned to the subject device)
GZJ, IPF
Device Description
The GEM-STIM TENS series, including GM3X0T/GM3AX0T, GM3X0E/GM3AX0E, GM3X0PP/GM3AX0PP, GM3X0PE/GM3AX0PE, and GM3X0TE/GM3AX0TE are transcutaneous electrical nerve stimulator used for pain relief and/or powered muscle stimulator by applying an electrical current to electrodes, which are attached on the patient's skin. The output and waveform is adjustable according to the situation of patient.
GEM-STIM TENS series, models GM3X0T/GM3AX0T, GM3X0E/GM3AX0E, GM3X0PP/GM3AX0PP, GM3X0PE/GM3AX0PE, and GM3X0TE/GM3AX0TE, consist mainly of two parts: the stimulus generator, electrode. The stimulus generates the output current specified as the input of controller. The output port transmits the output current to the electrode, which is attached to the patient's skin so as to transmit this stimulus current to the patient for pain relief.
The stimulation mode for GEM-STIM TENS includes several different operation modes as mentioned on the comparison table. These operation modes are generated from the software control by using the microprocessor as its main control unit.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Discussion of Non-Clinical Tests Performed Determination of Substantial Equivalence are as follows:
Compliance to applicable voluntary standards includes ANSI/AAMI, NS4-1985, as well as EN 60601-1, EN 60601-1-1, and EN 60601-1-2 requirement.
In addition to the compliance of voluntary standards, the software verification has been carried out according to the FDA software guidance.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 882.5890 Transcutaneous electrical nerve stimulator for pain relief.
(a)
Identification. A transcutaneous electrical nerve stimulator for pain relief is a device used to apply an electrical current to electrodes on a patient's skin to treat pain.(b)
Classification. Class II (performance standards).
0
DEC 1 0 2003
510(K) SUMMARY
Image /page/0/Picture/2 description: The image shows a sequence of handwritten alphanumeric characters. The characters are "K032720". The characters are written in black ink on a white background.
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
The assigned 510(k) number is:
- Submitter's Identifications: 1. GEMORE TECHNOLOGY CO., LTD. 11FL., NO. 29-5, Sec. 2, Chung Cheng E. RD., Tan Shui, Taipei Hsien, Taiwan
Contact: Boden S.P. Lai General Manager
Date of Summary Preparation: August 29,2003.
-
- Name of the Device:
GEM-STIM TENS/Model GM3XY and GM3AXY where "X" is parameter for different outlook which may be different from 0~5. "Y" is parameter for different operation type, which may be different with the parameter of "OT", "OE", "OPP", "OPE", and "OTE".
- Name of the Device:
-
Information of the 510(k) Cleared Device (Predicate Device): K021359 & K020314. 3.
-
- Device Description:
The GEM-STIM TENS series, including GM3X0T/GM3AX0T, GM3X0E/GM3AX0E, GM3X0PP/GM3AX0PP, GM3X0PE/GM3AX0PE, and GM3X0TE/GM3AX0TE are transcutaneous electrical nerve stimulator used for pain relief and/or powered muscle stimulator by applying an electrical current to electrodes, which are attached on the patient's skin. The output and waveform is adjustable according to the situation of patient.
GEM-STIM TENS series, models GM3X0T/GM3AX0T, GM3X0E/GM3AX0E, GM3X0PP/GM3AX0PP, GM3X0PE/GM3AX0PE, and GM3X0TE/GM3AX0TE, consist mainly of two parts: the stimulus generator, electrode. The stimulus generates the output current specified as the input of controller. The output port transmits the output current to the electrode, which is attached to the patient's skin so as to transmit this stimulus current to the patient for pain relief.
The stimulation mode for GEM-STIM TENS includes several different operation modes as mentioned on the comparison table. These operation modes are generated from the software control by using the microprocessor as its main control unit.
-
- Intended Use:
On the instruction manual of each model, the intended uses and contraindication are defined very clearly. Please see the information of instruction manuals in clause 7.6 of this submission document.
- Intended Use:
In addition, the standard format for the statement of indications and contraindication for use are provided hereafter.
1
ATTACHMENT 3-1
Page 1 of 1 .
2720 510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________
Device Name: GEM-STIM TENS/Model GM3XY and GM3AXY where "X" is parameter for different outlook, "X" may be different from 0~5, "Y" is parameter for different operation type, "Y" may be different with one of the following parameters, 'OT', 'OE', 'OPP', 'OPE' and 'OTE'.
Indications For Use (Available for GM3X0T/GM3AX0T, GM3X0PP/GM3AX0PP, and TENS function of GM3X0TE/GM3AX0TE):
This device is a prescription device and only for symptomatic relief of chronic intractable pain.
Indications For Use (Available for GM3X0E/GM3AX0E, & 'EMS function' of GM3X0TE/GM3AX0TE):
- Relaxation of muscle spasms. .
- · Prevention or retardation of disuse atrophy.
- Increasing local blood circulation.
- Muscle re-education. .
- Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis. ●
- Maintaining or increasing range of motion. .
Indications For Use (Available for GM3X0PE/GM3AX0PE):
- Relaxation of muscle spasms. .
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Optional Format 3-10-98)
2
KO32720
-
- Comparison to the 510(k) Cleared Device (Predicate Device):
- (1) The new model GM3X0T/GM3AX0T and GM3X0PP/GM3AX0PP are substantially equivalent to the Well-Life clear model WL-2203 (K021359).
- (2) The new model GM3XQE/GM3AX0E. GM3X0PE/GM3AX0PE are substantially equivalent to the Well-Life clear model WL-2204 (K020314).
- (3) The new model GM3X0TE/GM3AX0TE is substantially equivalent to the Well-Life clear model WL-2205 (K021359 & K020314).
-
- Discussion of Non-Clinical Tests Performed Determination of Substantial Equivalence are as follows:
Compliance to applicable voluntary standards includes ANSI/AAMI, NS4-1985, as well as EN 60601-1, EN 60601-1-1, and EN 60601-1-2 requirement.
In addition to the compliance of voluntary standards, the software verification has been carried out according to the FDA software guidance.
-
- Conclusions
The GEM-STIM TENS series, including GM3X0T/GM3AX0T, GM3X0E/GM3AX0E. GM3X0PP/GM3AX0PP, GM3X0PE/GM3AX0PE, and GM3X0TE/GM3AX0TE, have the same intended use and technological characteristics as the cleared device of WL-2203, WL-2204, and WL-2205. Moreover, verification and validation tests contained in this submission demonstrate that the difference in the submitted demonstrate that the difference in the submitted models could maintain the same safety and effectiveness as that of cleared device.
- Conclusions
In the other words, those engineering difference do not: (1) affect the intended use or (2) alter the fundamental scientific technology of the device.
3
Image /page/3/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or bird in flight, composed of three curved lines.
DEC 1 0 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Boden S.P. Lai General Manager Gemore Technology Co., Ltd. 11FL., No. 29-5, Sec. 2, Chung Cheng E. RD., Tan Shui, Taipei Hsien, Taiwan
Re: K032720
Trade/Device Name: GEM-STIM Models GM3X0T. GM3AX0T. GM3X0PP. and GM3AX0PP Regulation Number: 21 CFR 882.5890 Regulation Name: Transcutaneous electrical nerve stimulator for pain relief Regulatory Class: II Product Code: GZJ
Trade/Device Name: GEM-STIM Models GM3X0E, GMAX0E, GM3X0PE, and GM3X0PE Regulation Number: 21 CFR 890.5850 Regulation Name: Powered muscle stimulator Regulatory Class: II Product Code: IPF
Trade/Device Name: GEM-STIM Models GM3X0TE and GM3AX0TE Regulation Numbers: 21 CFR 890.5850, 21 CFR 882.5890 Regulation Names: Powered muscle stimulator, Transcutaneous electrical nerve stimulator for pain relief Regulatory Class: II Product Codes: IPF, GZJ
Dated: July 21, 2003 Received: September 12, 2003
Dear Mr. Lai:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments. or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act - The general controls provisions of the Act include requirements for annual registration. Ilsuing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
4
Page 2 - Mr. Boden S.P. Lai
If your device is classified (see above) into cither class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the
Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely vours.
b Mark A. Melkerson
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
ATTACHMENT 3-1
Page
510(k) Number (if known):
Device Name: GEM-STIM TENS/Model GM3XY and GM3AXY where "X" is parameter for different outlook, "X" may be different from 0~5, "Y" is parameter for different operation type, "Y" may be different with one of the following
parameters_ '0T', '0E', '0PP', '0PE' and '0TE'.
Indications For Use (Available for GM3X0T/GM3AX0T, GM3X0PP/GM3AX0PP, and TENS function of GM3X0TE/GM3AX0TE):
I his fullietion of Gillering of Giller and only for symptomatic relief of chronic intractable pain.
Indications For Use (Available for GM3X0E/GM3AX0E, & 'EMS function' of GM3X0TE/GM3AX0TE):
- Relaxation of muscle spasms. .
- Prevention or retardation of disuse atrophy. .
- Increasing local blood circulation. �
- Muscle re-education. ●
- Muscle re oudouloni
Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis. . - Maintaining or increasing range of motion. .
Indications For Use (Available for GM3X0PE/GM3AX0PE):
- Relaxation of muscle spasms. .
Image /page/5/Picture/17 description: The image shows the text "Prescription Use (Part 21 CFR 801 Subpart D)". There is a line underneath the text with an X above the line. The text is in a simple, sans-serif font and is left-aligned.
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(Please do not write below this line-continue on another page if needed)
Concurrence of CDRH, O
Mark A. Millerson
(Optional Format 3-10-98)
evice Evaluation (ODE)
K030720 Page 2 of 3